22nd International Vascular Biology Meeting

第22届国际血管生物学会议

基本信息

  • 批准号:
    10391915
  • 负责人:
  • 金额:
    $ 6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-01-20 至 2022-12-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Since its inception in 1980, the International Vascular Biology Meeting (IVBM) has been a time-honored and profoundly impactful biennial event. This meeting provides a unique opportunity for the global community to exchange and discuss new scientific discoveries, and to chart innovative and collaborative future scientific directions in vascular biology. The IVBM has also served to foster the next generation of scientists in vascular medicine. IVBM 2022 (October 13-17, 2022 in Oakland, CA) will cover a broad spectrum of vascular biology, prioritizing emerging areas of research. The vasculature impacts every organ system in development, aging, and disease and is critical to processes of regeneration. Blood vessel walls regulate multiple physiological functions, including vasomotor tone, leukocyte trafficking, innate and acquired immunity, permeability, stem cell differentiation, regeneration, and new blood formation. Abnormalities in any of these functions lead to disease. Beyond traditional vessel wall pathologies such as atherosclerosis and hypertension, the vasculature contributes to cancer, neurological disease, diabetes, hematological and immunological disorders, aging, and infectious processes, most recently COVID-19. Mounting evidence suggests that many COVID-19 symptoms are due to the virus attacking the vasculature. Advances in vascular biology have led to the development of many new therapies and preventive strategies with broad impact including those mitigating tumor growth and restoring vision. IVBM 2022 will provide a timely forum to exchange new knowledge in the rapidly expanding field of vascular biology, facilitate cross-disciplinary collaboration and critical interactions between seasoned investigators and trainees, and promote awareness of diverse vascular beds in health and disease. Our objective is to ignite novel areas of research between academia and industry, and from basic to translational research and clinical medicine, with the ultimate goal of improving human health. IVBM 2022 is being organized by the North American Vascular Biology Organization (NAVBO), an organization with a strong track record of promoting trainees and junior faculty. A significant number of oral presentations are reserved for junior scientists to promote their career growth. NAVBO is committed to diversity and equity within and beyond the vascular biology community; the IVBM organizers and speakers include women, junior faculty, underrepresented groups, and scientists from around the world. We selected the diverse city of Oakland, CA as the conference site. Our program facilitates cross-fertilization of scientific insights related to different vascular beds (brain, heart, lung, kidney, liver, and eye) and diverse disciplines (cell biology, genetics, imaging, bioengineering, mathematics, physics, systems biology, translational research, and drug discovery). By promoting such interactions, we will generate new basic knowledge of developmental and disease processes, catalyze innovation, and expedite development of new diagnostic, regenerative and other therapeutic approaches. By engaging young investigators and fostering diversity we will enrich the field of vascular biology and secure its future.
项目摘要 自1980年成立以来,国际血管生物学会议(IVBM)一直是一个历史悠久, 影响深远的两年一度的活动。这次会议为国际社会提供了一个独特的机会, 交流和讨论新的科学发现,并规划创新和合作的未来科学 血管生物学方向。IVBM还有助于培养下一代血管科学家, 药IVBM 2022(2022年10月13日至17日,加利福尼亚州奥克兰)将涵盖广泛的血管生物学, 优先考虑新兴的研究领域。脉管系统影响发育、衰老和衰老过程中的每个器官系统, 疾病,并对再生过程至关重要。血管壁调节多种生理功能, 包括血管紧张素、白细胞运输、先天性和获得性免疫、渗透性、干细胞 分化、再生和新血液形成。这些功能中的任何一个功能缺失都会导致疾病。 除了动脉粥样硬化和高血压等传统的血管壁病变外, 癌症、神经系统疾病、糖尿病、血液学和免疫学疾病、衰老和传染病 过程,最近是COVID-19。越来越多的证据表明,许多COVID-19症状是由于 病毒攻击脉管系统血管生物学的进步导致了许多新的 具有广泛影响的治疗和预防策略,包括减缓肿瘤生长和恢复 视野IVBM 2022将提供一个及时的论坛,以交流在快速扩大的领域的新知识, 血管生物学,促进跨学科合作和经验丰富的 研究人员和受训人员,并促进对健康和疾病中各种血管床的认识。我们的目标 是点燃学术界和工业界之间的研究新领域,从基础到转化研究, 临床医学,以改善人类健康为最终目标。IVBM 2022由北方组织 美国血管生物学组织(NAVBO),一个在促进 实习生和初级教员。相当数量的口头报告是留给年轻科学家的, 他们的职业成长。NAVBO致力于血管生物学内外的多样性和公平性 社区; IVBM的组织者和发言人包括妇女,初级教师,代表性不足的群体, 来自世界各地的科学家。我们选择了多样的城市奥克兰,加利福尼亚州作为会议地点。我们 该计划促进了与不同血管床(脑,心,肺, 肾、肝和眼)和不同学科(细胞生物学、遗传学、成像、生物工程、数学, 物理学、系统生物学、转化研究和药物发现)。通过促进这种互动,我们将 产生关于发育和疾病过程的新的基础知识,促进创新, 开发新的诊断、再生和其他治疗方法。通过吸引年轻人 研究人员和促进多样性,我们将丰富血管生物学领域,并确保其未来。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rong Wang其他文献

Rong Wang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rong Wang', 18)}}的其他基金

Molecular Pathogenesis of Hereditary Hemorrhagic Telangiectasia
遗传性出血性毛细血管扩张症的分子发病机制
  • 批准号:
    10083767
  • 财政年份:
    2020
  • 资助金额:
    $ 6万
  • 项目类别:
Molecular Pathogenesis of Hereditary Hemorrhagic Telangiectasia
遗传性出血性毛细血管扩张症的分子发病机制
  • 批准号:
    10339385
  • 财政年份:
    2020
  • 资助金额:
    $ 6万
  • 项目类别:
Molecular Pathogenesis of Hereditary Hemorrhagic Telangiectasia
遗传性出血性毛细血管扩张症的分子发病机制
  • 批准号:
    9917601
  • 财政年份:
    2020
  • 资助金额:
    $ 6万
  • 项目类别:
Molecular Pathogenesis of Hereditary Hemorrhagic Telangiectasia
遗传性出血性毛细血管扩张症的分子发病机制
  • 批准号:
    10614453
  • 财政年份:
    2020
  • 资助金额:
    $ 6万
  • 项目类别:
Comparative Effectiveness of Treatments for Acute Myeloid Leukemia in the Elderly
老年人急性髓系白血病治疗的比较疗效
  • 批准号:
    8693973
  • 财政年份:
    2013
  • 资助金额:
    $ 6万
  • 项目类别:
Comparative Effectiveness of Treatments for Acute Myeloid Leukemia in the Elderly
老年人急性髓系白血病治疗的比较疗效
  • 批准号:
    8583443
  • 财政年份:
    2013
  • 资助金额:
    $ 6万
  • 项目类别:
Molecular pathogenesis and treatment of brain arteriovenous malformation
脑动静脉畸形的分子发病机制及治疗
  • 批准号:
    8117203
  • 财政年份:
    2010
  • 资助金额:
    $ 6万
  • 项目类别:
Molecular Pathogenesis of Brain Arteriovenous Malformation
脑动静脉畸形的分子发病机制
  • 批准号:
    9242700
  • 财政年份:
    2010
  • 资助金额:
    $ 6万
  • 项目类别:
Molecular pathogenesis and treatment of brain arteriovenous malformation
脑动静脉畸形的分子发病机制及治疗
  • 批准号:
    7987203
  • 财政年份:
    2010
  • 资助金额:
    $ 6万
  • 项目类别:
Molecular pathogenesis and treatment of brain arteriovenous malformation
脑动静脉畸形的分子发病机制及治疗
  • 批准号:
    8269939
  • 财政年份:
    2010
  • 资助金额:
    $ 6万
  • 项目类别:

相似海外基金

Indicators of Accelerated Aging in Asian American Childhood Survivors
亚裔美国童年幸存者加速衰老的指标
  • 批准号:
    10910604
  • 财政年份:
    2023
  • 资助金额:
    $ 6万
  • 项目类别:
Longitudinal Examination of Neighborhood Disadvantage, Cognitive Aging, and Alzheimer's Disease Risk in Disinvested, African American Neighborhoods
对投资撤资的非裔美国人社区的社区劣势、认知老化和阿尔茨海默病风险进行纵向调查
  • 批准号:
    10370185
  • 财政年份:
    2022
  • 资助金额:
    $ 6万
  • 项目类别:
50th Annual Meeting of the American Aging Association
美国老龄化协会第 50 届年会
  • 批准号:
    10468570
  • 财政年份:
    2022
  • 资助金额:
    $ 6万
  • 项目类别:
Longitudinal Examination of Neighborhood Disadvantage, Cognitive Aging, and Alzheimer's Disease Risk in Disinvested, African American Neighborhoods
对投资撤资的非裔美国人社区的社区劣势、认知老化和阿尔茨海默病风险进行纵向调查
  • 批准号:
    10565869
  • 财政年份:
    2022
  • 资助金额:
    $ 6万
  • 项目类别:
51st Annual Meeting of the American Aging Association
美国老龄化协会第 51 届年会
  • 批准号:
    10602831
  • 财政年份:
    2022
  • 资助金额:
    $ 6万
  • 项目类别:
Advancing Native American Diversity in Aging Research through Undergraduate Education (Native American ADAR)
通过本科教育促进美国原住民老龄化研究的多样性(美国原住民 ADAR)
  • 批准号:
    10460942
  • 财政年份:
    2021
  • 资助金额:
    $ 6万
  • 项目类别:
Advancing Native American Diversity in Aging Research through Undergraduate Education (Native American ADAR)
通过本科教育促进美国原住民老龄化研究的多样性(美国原住民 ADAR)
  • 批准号:
    10172529
  • 财政年份:
    2021
  • 资助金额:
    $ 6万
  • 项目类别:
Diversity Supplement to Psychosocial Stress due to COVID-19 and Vascular Aging in African-American Women
对非裔美国女性因 COVID-19 和血管老化造成的心理社会压力进行多样性补充
  • 批准号:
    10709289
  • 财政年份:
    2021
  • 资助金额:
    $ 6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了